HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,820,199 | +12.5% | 33,021 | 0.0% | 0.01% | +11.1% |
| Q2 2023 | $3,396,209 | -5.8% | 33,021 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $3,603,912 | -25.2% | 33,021 | -22.0% | 0.01% | -28.6% |
| Q4 2022 | $4,816,243 | +55.4% | 42,322 | -15.5% | 0.01% | +40.0% |
| Q3 2022 | $3,099,000 | -17.3% | 50,083 | +6.6% | 0.01% | -16.7% |
| Q2 2022 | $3,748,000 | +467.9% | 46,986 | +650.5% | 0.01% | +500.0% |
| Q1 2022 | $660,000 | -82.3% | 6,261 | -81.9% | 0.00% | -75.0% |
| Q4 2021 | $3,721,000 | +53.4% | 34,528 | +55.9% | 0.01% | +60.0% |
| Q3 2021 | $2,426,000 | -46.3% | 22,147 | -54.0% | 0.01% | -50.0% |
| Q2 2021 | $4,514,000 | +0.2% | 48,198 | -1.5% | 0.01% | -9.1% |
| Q1 2021 | $4,506,000 | +14.2% | 48,945 | -9.3% | 0.01% | +10.0% |
| Q4 2020 | $3,946,000 | +1472.1% | 53,961 | +1568.6% | 0.01% | +900.0% |
| Q3 2020 | $251,000 | – | 3,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |